A review of genetic polymorphisms and prostate cancer risk (Q34565351)

3 August 2017

0 references

A review of genetic polymorphisms and prostate cancer risk (English)

1 reference

3 August 2017

1 reference

Steven S Coughlin

1

1 reference

3 August 2017

Ingrid J Hall

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

published in

Annals of Epidemiology

1 reference

3 August 2017

volume

12

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

182-196

1 reference

publication type of scholarly work

3 August 2017

review article

1 reference

Family history and the risk of prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Mendelian inheritance of familial prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Family history of prostate cancer: A multi-center case-control study in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Familial prostate cancer in Sweden. A nationwide register cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Evidence for a prostate cancer susceptibility locus on the X chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Prostate Cancer Potentially Linked to the HPC1 Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Molecular genetics and epidemiology of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

The emerging importance of genetics in epidemiologic research II. Issues in study design and gene mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Re: Prostate cancer and the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Links between genetic and environmental factors and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Unusual length polymorphism in human steroid 5 alpha-reductase type 2 gene (SRD5A2)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Vitamin D receptor gene polymorphism in Japanese patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Vitamin D receptor polymorphisms as markers in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Genetic metabolic polymorphisms and the risk of cancer: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Functional significance of different human CYP1A1 genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

A polymorphism in the CYP17 gene is associated with prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Glutathione S-transferases as risk factors in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Epidemiology of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Why genes don't count (for racial differences in health)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

Cancer risk and low-penetrance susceptibility genes in gene-environment interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900310-6

7 January 2021

10.1016/S1047-2797(01)00310-6

Identifiers

DOI

1 reference

3 August 2017

1 reference